Support By : Li-lab
| PATHWAY_NAME | REACTOME_ID | KEGG_ID | DRUG_NAME | PUBCHEM_CID | Datasource |
|---|---|---|---|---|---|
| Natural killer cell mediated cytotoxicity | R-HSA-5218921 | map04650 | proadifen | 667484 | drug-path |
| Ubiquitin mediated proteolysis | R-HSA-983153 | map04120 | proadifen | 667484 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | proadifen | 667484 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | proadifen | 667484 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | proadifen | 667484 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | proadifen | 667484 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | proadifen | 667484 | drug-path |
| Olfactory transduction | R-HSA-9751605 | map04740 | sulfanilamide | 5333 | drug-path |
| Systemic lupus erythematosus | R-HSA-977105 | map05322 | sulfanilamide | 5333 | drug-path |
| Graft-versus-host disease | R-HSA-1643685 | map05332 | sulfanilamide | 5333 | drug-path |
| Hematopoietic cell lineage | R-HSA-173752 | map04640 | sulfanilamide | 5333 | drug-path |
| Autoimmune thyroid disease | R-HSA-1643685 | map05320 | sulfanilamide | 5333 | drug-path |
| Antigen processing and presentation | R-HSA-1236975 | map04612 | sulfanilamide | 5333 | drug-path |
| Adherens junction | R-HSA-451386 | map04520 | sulfanilamide | 5333 | drug-path |
| Cell adhesion molecules (CAMs) | R-HSA-1031690 | 0 | sulfanilamide | 5333 | drug-path |
| Circadian rhythm - mammal | R-HSA-400253 | 0 | sulfanilamide | 5333 | drug-path |
| Melanoma | Q9UHD0-PRO_0000015379 | map05218 | sulfanilamide | 5333 | drug-path |
| Asthma | R-HSA-444620 | map05310 | sulfanilamide | 5333 | drug-path |
| Allograft rejection | R-HSA-9679028 | map05330 | sulfanilamide | 5333 | drug-path |
| Type I diabetes mellitus | R-HSA-5683209 | map04940 | sulfanilamide | 5333 | drug-path |